Adaptive servo- ventilation instruments
Airway clearance systems
Others
2. Diagnostic devices- These are further sub- segmented as:
Polysomnography (PSG) devices
Respiratory polygraphs
Single channel screening devices
Actigraphy systems
On the basis of end user, the global market can be segmented as:
1.
2.
3.
4.
Hospitals
Home Care Settings
Sleep Laboratories
Others
Inquire Here Before Purchase of Research Report @
https://www.coherentmarketinsights.com/insight/talk-to-analyst/414
The North American share to contribute the highest of the sleep apnea devices market
North America dominates the global sleep apnea devices market, followed by Europe and Asia
Pacific respectively. High awareness among the populace and favorable reimbursement scenario
make North America a key market for sleep apnea devices. Several other factors such as
venture capital funding, new legislation of PAP devices and growth of funding and grants for
development in manufacturing units of sleep apnea devices are prime reasons to boost market
growth in several European countries.
Well established presence of multiple sleep apnea treating devices results in dominance of
ResMed Inc (US) on global sleep apnea devices market
The global sleep apnea devices market is prominently driven by key players such as ResMed
Inc., Phillips Healthcare, Fisher and Paykel Healthcare Ltd. These companies have their products
selling over several countries, prominently in US and Europe, and has established a dominance
in the field of sleep apnea devices industry due to their high investments in R&D and
distribution force of strong sales. Following are the other players in global sleep apnea devices
market which include SomnoMed Ltd., Weinmann Medical Devices GmbH, Compumedics Ltd.,
Whole You Inc., BMC Medical Co. Ltd, and Braebon Medical Corporation.